CIK 0001827635 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Veradermics, Inc
Sign in to watch- Ticker
- MANE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843304423
- Phone
- 228.372.3376
- Business address
- 470 JAMES STREET, NEW HAVEN, CT, 06513
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $242,788,217
- in 5 filings, $12.0M under 10b5-1 plans
Net −$242,788,217. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MONTANOVA CAPITAL, LLC −$80.4M Director sold 62% of stake
- ENRIGHT PATRICK G −$75.2M Director sold 22% of stake
- Longitude Capital Partners V, LLC −$75.2M 10% owner sold 22% of stake
- Waldman Reid Alexander −$7.3M Chief Executive Officer sold 28% of stake
- Durso Timothy August −$4.7M Chief Technical Officer sold 36% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-05 | Durso Timothy August Chief Technical Officer | Conversion | +1,473 | 118,190 | ||
| 2026-02-05 | Durso Timothy August Chief Technical Officer | Conversion · Series A Convertible Preferred Stock | −1,473 | 0 | ||
| 2026-02-05 | Waldman Reid Alexander Chief Executive Officer | Conversion | +1,437 | 234,872 | ||
| 2026-02-05 | Waldman Reid Alexander Chief Executive Officer | Conversion · Series A Convertible Preferred Stock | −1,437 | 0 | ||
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +10,004 | $34.25 | $343K | 3,525,462 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +10,676 | $34.74 | $371K | 3,536,138 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +14,659 | $36.27 | $532K | 3,550,797 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +53,344 | $37.11 | $2.0M | 3,604,141 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +25,908 | $38.09 | $987K | 3,630,049 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +18,489 | $38.90 | $719K | 3,648,538 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +1,720 | $34.25 | $59K | 372,579 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +1,835 | $34.74 | $64K | 374,414 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +2,519 | $36.27 | $91K | 376,933 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +9,168 | $37.11 | $340K | 386,101 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +4,453 | $38.09 | $170K | 390,554 |
| 2026-02-04 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +3,178 | $38.90 | $124K | 393,732 |
| 2026-02-03 | Grant-Kels Jane M. Director | Grant or award · Stock Option (Right to Buy) | +51,525 | 51,525 | ||
| 2026-02-03 | Friedman David Matthew Director | Grant or award · Stock Option (Right to Buy) | +43,000 | 43,000 | ||
| 2026-02-03 | Coric Vlad Director | Grant or award · Stock Option (Right to Buy) | +51,525 | 51,525 | ||
| 2026-02-03 | CHILDS JOHN W Director | Grant or award · Stock Option (Right to Buy) | +51,525 | 51,525 |
Page 5 of 6 · 107 trades